A detailed history of Burney CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Burney CO holds 63,020 shares of ABBV stock, worth $11.3 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
63,020
Previous 58,348 8.01%
Holding current value
$11.3 Million
Previous $10 Million 24.36%
% of portfolio
0.49%
Previous 0.42%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $765,460 - $931,269
4,672 Added 8.01%
63,020 $12.4 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $259,582 - $303,134
-1,677 Reduced 2.79%
58,348 $10 Million
Q1 2024

May 22, 2024

SELL
$159.82 - $182.1 $46,507 - $52,991
-291 Reduced 0.48%
60,025 $10.9 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $556,454 - $626,698
4,044 Added 7.19%
60,316 $9.35 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $32,328 - $37,425
242 Added 0.43%
56,272 $8.39 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $129,859 - $161,602
-980 Reduced 1.72%
56,030 $7.55 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $1.97 Million - $2.26 Million
-13,589 Reduced 19.25%
57,010 $9.09 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $266,799 - $319,963
-1,929 Reduced 2.66%
70,599 $11.4 Million
Q3 2022

Nov 15, 2022

BUY
$134.21 - $153.93 $58,515 - $67,113
436 Added 0.6%
72,528 $9.73 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $274,551 - $349,045
-1,995 Reduced 2.69%
72,092 $11 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $95,025 - $117,900
-720 Reduced 0.96%
74,087 $12 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $173,499 - $219,526
-1,615 Reduced 2.11%
74,807 $10.1 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $85,439 - $96,986
-803 Reduced 1.04%
76,422 $8.24 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $128,777 - $143,465
1,224 Added 1.61%
77,225 $8.7 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $506,078 - $557,131
4,947 Added 6.96%
76,001 $8.23 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $86,446 - $116,711
1,074 Added 1.53%
71,054 $7.61 Million
Q3 2020

Dec 14, 2020

SELL
$85.91 - $100.83 $445,443 - $522,803
-5,185 Reduced 6.9%
69,980 $6.13 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $317,838 - $425,315
4,332 Added 6.12%
75,165 $7.38 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $151,833 - $230,197
2,354 Added 3.44%
70,833 $5.4 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $183,859 - $230,047
2,549 Added 3.87%
68,479 $6.06 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $1.87 Million - $2.25 Million
-29,732 Reduced 31.08%
65,930 $4.99 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $625,069 - $798,985
-9,514 Reduced 9.05%
95,662 $6.96 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $79,917 - $94,058
-1,036 Reduced 0.98%
105,176 $8.48 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $108,211 - $133,453
1,390 Added 1.33%
106,212 $9.79 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $4.48 Million - $4.98 Million
-50,425 Reduced 32.48%
104,822 $9.91 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $539,577 - $638,442
6,010 Added 4.03%
155,247 $14.4 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $1.13 Million - $1.51 Million
-12,251 Reduced 7.59%
149,237 $14.1 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $883,867 - $969,234
9,869 Added 6.51%
161,488 $15.6 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $391,090 - $499,542
-5,599 Reduced 3.56%
151,619 $13.5 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $11 Million - $14 Million
157,218
157,218 $11.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.